All the latest news from Llanelli from Sigma Recruitment Agency.
Llanelli based Chromogenex Holdings has raised money from a US medical technology investor
The Llanelli developer and manufacturer of laser and intense pulse light systems received the funding from Squadron Capital in the USA.
Chromogenex’s technology is used for aesthetic, non-invasive procedures for a range of conditions, including vascular and pigmented lesions, psoriasis and acne, as well as permanent hair removal, skin rejuvenation and fat reduction.
The company has won the Mediwales export award for teh aklst two years.
Chief executive Peter McGuinness said: “We are delighted to have completed this deal and to welcome Squadron on board to create a strong consolidated shareholder base and provide the funding to support our ambitious growth plans for the business. We can now look forward to our next phase of development with confidence.”
